Status:

TERMINATED

Prehypertension Labeling

Lead Sponsor:

Columbia University

Conditions:

Prehypertension

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to find out whether labeling adults with prehypertension has negative effects on clinic blood pressure and quality of life 3 months after diagnosis.

Detailed Description

Previous research has shown that a diagnosis of hypertension is associated with subsequent increases in resting blood pressure, and there is preliminary evidence of a cross-sectional association betwe...

Eligibility Criteria

Inclusion

  • at least 18 years
  • average screening systolic blood pressure of 120-139 mmHg OR diastolic blood pressure of 80-89 mmHg
  • average screening systolic blood pressure below 140 mmHg AND diastolic blood pressure below 90 mmHg
  • able to read and write in English

Exclusion

  • past diagnosis of hypertension, prehypertension, or high blood pressure
  • current or past use of antihypertensive medications
  • diabetes
  • renal disease
  • cardiovascular disease
  • current participation in another hypertension-related clinical trial

Key Trial Info

Start Date :

July 13 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 9 2012

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01434953

Start Date

July 13 2009

End Date

July 9 2012

Last Update

July 17 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Columbia University Medical Center

New York, New York, United States, 10032

Prehypertension Labeling | DecenTrialz